AARP Highlights BASHIR™ Endovascular Catheter in ‘Medical Breakthroughs’ Series, Interviews Co-Inventor Dr. Riyaz Bashir

AARP highlighted the BASHIR™ Endovascular Catheter (THROMBOLEX, Inc.), invented at the Lewis Katz School of Medicine at Temple University and developed by Thrombolex Inc., in its “Medical Breakthroughs” series. The catheter was approved by the U.S. Food and Drug Administration (FDA) for the treatment of acute pulmonary embolism back in the spring. Riyaz Bashir, MD, FACC, Director of Vascular and Endovascular Medicine at Temple University Hospital, is co-inventor of the BASHIR™ Endovascular Catheter and was interviewed for the AARP article.